Zepp Health Corporation’s SEC filings document a foreign private issuer whose American depositary shares each represent sixteen Class A ordinary shares. The company files current reports on Form 6-K and annual reporting on Form 20-F covering its smart wearable and health technology business, including Amazfit-branded products and the Zepp Digital Management Platform.
The filings and exhibits record unaudited operating results, revenue and margin commentary, cash, inventory and loan balances, product launches, capital-structure actions, risk factors, governance matters and ADR-related disclosure. They also provide formal disclosure around periodic results releases and other material information furnished by the company to U.S. markets.
Zepp Health Corp reports an amended Schedule 13G/A showing 11,477,632 shares of Class A common stock beneficially owned, equal to 10.0% of the class as of 03/31/2026. The filing identifies FIL Limited and affiliated entities as the reporting holders.
The disclosure states that Fidelity Funds - China Focus holds 5,998,048 shares or 5.2% of Class A common stock as of 03/31/2026. Signatures show transactions are reported via power of attorney and include Exhibit 99 references.
Zepp Health Corporation files its annual report detailing a global smart wearables and health-technology business built around Amazfit, Zepp Clarity and Zepp Aura brands. For 2025, it generated $258.9M in revenue and reported a net loss of $40.1M.
The company operates through a Cayman holding structure with significant activities in China conducted via consolidated VIEs, whose revenue contribution fell from 40.1% in 2023 to 8.0% in 2025. Zepp highlights legal and operational risks from PRC regulation, VIE enforceability, data security oversight, and potential impacts of the HFCAA on U.S. trading.
Zepp changed its reporting currency from Renminbi to U.S. dollars in 2024 and effected an ADS ratio change so that one ADS now represents 16 Class A shares. As of December 31, 2025, it had 135,608,316 Class A and 99,277,687 Class B ordinary shares outstanding.
Zepp Health Corp director Xie Bing (Brian) has filed an initial statement of beneficial ownership on Form 3. The filing establishes his status as a director and does not report any insider buy, sell, or other share transactions.
Zepp Health Corp director Lai Jimmy Y. filed an initial statement of beneficial ownership on Form 3. This filing establishes his status as a reporting insider under securities rules and does not report any stock purchases, sales, or other transactions in Zepp Health shares.
Zepp Health Corp Chief Technology Officer Meihui Fan has filed an initial statement of beneficial ownership, detailing existing equity and option interests rather than new trades. The filing lists several option awards over Class A ordinary shares with a conversion or exercise price of US$0.0000, covering 160,000, 200,000, 80,000 and 80,000 underlying Class A shares with expirations between 2031 and 2034. It also reports indirect holdings of 432,000 Class A ordinary shares and 3,450,746 Class B ordinary shares held by Fandler Holding Limited, which is ultimately owned by a trust for Mr. Fan and his family members. In addition, Mr. Fan directly holds 10,000 American depositary shares, with each ADS representing 16 Class A ordinary shares.
Zepp Health Corp Chief Financial Officer Deng Cheng filed an initial ownership report on Form 3, showing direct holdings of 101,500 American depositary shares (ADSs). Each ADS represents 16 Class A ordinary shares, meaning this filing simply discloses his existing equity stake rather than reporting a new stock transaction.
Zepp Health Corp executive Wang Hui, VP of Corporate Strategy, has filed an initial ownership report showing a substantial equity stake. He directly holds 1,495,500 Class A ordinary shares and several option awards over additional Class A shares, each with a $0.0000 exercise price and expirations ranging from 2030 to 2034. These entries reflect existing holdings rather than new market purchases or sales.
Zepp Health Corp director and Chief Operating Officer Mike Yan Yeung filed an initial ownership report showing his holdings in the company. He reported Class A ordinary shares and separate holdings of American depositary shares (ADSs). Each ADS represents 16 Class A ordinary shares, according to the disclosure.
Zepp Health Corp insider Yu Pengtao, the company’s Chief Industrial Designer, filed an initial ownership report showing holdings of 108,491 American depositary shares. Each ADS represents 16 Class A ordinary shares, so this filing mainly establishes his existing equity stake rather than reporting a new trade.
Zepp Health Corp director and CEO Huang Wang filed an initial ownership report showing substantial holdings in the company. He indirectly owns 65,836,680 Class B ordinary shares through HHtech Holdings Limited, which is ultimately owned by a trust established for the benefit of Mr. Wang and his family members.
He also indirectly holds 237,500 American depositary shares (ADSs) through HHtech Holdings Limited and directly holds 60,076 ADSs. Each ADS represents 16 Class A ordinary shares, giving him significant economic exposure and voting influence over Zepp Health.